Join
Live feed
·
PRReleasevia Quantisnow
Immunovant Inc. logo

Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

ByQuantisnow·Wall Street's wire, on your screen.
IMVT· Immunovant Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMVT (Immunovant Inc.) and more on Quantisnow.